A Review on Ayurvedic Medicinal Herbs as Remedial Perspective for COVID-19

Authors

  • Rajendra Gyawali Associate Professor, Department of Pharmacy, Kathmandu University, Nepal
  • Prem Narayan Paudel Department of Chemical Science and Engineering, Kathmandu University, Dhulikhel, Nepal
  • Dipak Basyal Department of Pharmacy, Tribhuvan University, Maharajgunj, Kathmandu, Nepal
  • William N Setzer Department of Chemistry, The University of Alabama in Huntsville, USA
  • Saroj Lamichhane Research and Development Department, Phytomax Care Pvt Ltd, Bharatpur 10, Chitawan Nepal.
  • Madan Kumar Paudel Research and Development Department, Phytomax Care Pvt Ltd, Bharatpur 10, Chitawan Nepal
  • Shaphal Gyawali Nepal Medical College, Kathmandu University, Jorpati, Kathmandu, Nepal
  •  Prajwal Khanal Kathmandu Medical College, Kathmandu University, Sinamangal, Kathmandu, Nepal

Keywords:

SARS-CoV-2, Ayurvedic Medicine, Antiviral herbs, Immunity boosting, Phytochemicals, COVID-19 Preventive measures, Traditional Medicine, Nepal and COVID-19 pandemic

Abstract

Introduction: Recent outbreaks in a new type of coronavirus, novel coronavirus (COVID-19) disease causing respiratory infection have significantly hampered the public health. Medicinal plants used in traditional practices provide enormous scope to bring out viable alternatives against viral diseases, considering non-availability of suitable drug and increasing resistance to existing drug as well as re-emerging viral diseases. The present review on use of plants and related phytochemicals for the treatment of viral diseases particularly COVID-19, preclinical and clinical information is increased concern

Methods: The methodological activities involved during a literature review were; (1) designing the review concept, (2) conducting the review on review papers, research papers, bulletins, official websites, (3) analysis of previous publications and (4) writing up the review paper. The integrative literature review and paper preparation process was done from our own practical experience and influenced by various standards and guidelines suggested in the publications.

Results: Herbal medicines and their active phytochemicals against some viral pathogens including severe acute respiratory syndrome (SARS), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) the virus that causes COVID-19 pandemic, middle east respiratory syndrome (MERS-COV), rhinovirus, human herpes virus (HSV-I & II), human immunodeficiency virus (HIV), coxsackievirus (CV), enterovirus 71 (EV71), hepatitis B virus (HBV), hepatitis C virus (HCV), herpes simplex virus, influenza A/H1N1 virus, coronavirus (CoV) etc were extensively reviewed. Ayurvedic herbal products could be useful to select as an alternative and integrated approach to decrease the morbidity and mortality associated with coronavirus infection and enhance host immunity against viral attack in the context of treatment vaccine of COVID-19 could be years away.

Conclusion: The traditional practices and scientific evidence of several medicinal herbs and their phytochemicals against lethal viral infections in-vivo and in-vitro studies could be useful for the future as a novel source of natural products in particular focus on COVID-19.

Downloads

Published

2020-05-26

How to Cite

1.
Gyawali R, Paudel PN, Basyal D, Setzer WN, Lamichhane S, Paudel MK, Gyawali S, Khanal Prajwal. A Review on Ayurvedic Medicinal Herbs as Remedial Perspective for COVID-19. Journal of Karnali Academy of Health Sciences [Internet]. 2020May26 [cited 2024Dec.21];3. Available from: https://jkahs.org.np/jkahs/index.php/jkahs/article/view/237

Issue

Vol. 3 (2020): COVID-19 Special Issue

Section

Review Articles

License

The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).

Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).

More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below:  https://creativecommons.org/licenses/by/4.0/